Role of cytokines and growth factors in promoting the local recurrence of breast cancer

British Journal of Surgery

Volumn 83, Issue 9, 1996, Pages 1303-1304

  Mokbel, K ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH PROMOTOR;

BREAST TUMOR; HUMAN; NOTE; TUMOR RECURRENCE;

BREAST NEOPLASMS; CYTOKINES; GROWTH SUBSTANCES; HUMANS; NEOPLASM RECURRENCE, LOCAL;

EID: 0030226703     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.1800830943     Document Type: Letter

References (10)

1. Reed MJ, Singh A, Ghilchik MW et a/. Regulation of oestradiol 17 /I-hydroxysteroid dehydrogenase in breast tissues: the role of growth factors. J St&oid-Biochern Mol Biol 1991; 39: 791-8.
2. Singh A, Reed MJ. Insulin-like growth factor type 1 and insulin-like growth factor type I1 stimulate 17-p-hydroxysteroid dehydrogenase (reductive) activity in breast cancer cells. J Endocrinol 1991; 129: R5-R8.
3. Reed MJ, Coldham NG, Patel SR et a/. Interleukin-1 and interleukin-6 in breast cyst fluid: their role in regulating aromatase activity in breast cancer cells. J. Endocrinil 199z 132: R5-Ii8.
4. Miller ER, O'Neil JS. The importance of local synthesis of oestrogen within the breast. Steroids 1987;50: 537-47.
5. Purohit A, Ghilchik MW, Duncan DY et al. Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab 1995; 80: 3052-8.
6. Bulun SE, Price TM, Aitken J et al. A link between breast cancer and local oestrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytocrome P450 transcripts using competitive PCR after reverse transcription. J Clin Endocrinol Metab 1993; 77: 1622-8.
7. Miller WR, Mullen P. Factors influencing aromatase activity in the breast. J Steroid Biochem Mol Biol 1993; 44: 597-604.
8. Stewart T, Tsai JS, Grayson H et al. Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet 1995;346: 796-8.
9. Robinson E, Rubin D, Mekori T et a/. In vivo modulation of natural killer cell reactivity by tamoxifen in patients with bilateral primary breast cancer: Cancer Irnrnunoi Irnrnunother 1993: 37: 209-12.
10. Schnit SJ, Hayman J, Gelman R et a/. A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer 1996; 77: 1094-100.